Drug Manufacturers—General Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1993 | PVLA Palvella Therapeutics, Inc. - Common Stock | 145.85 USD | +2.68% | -5.00% | +4.70% | +97.49% | 2.10 B USD | ||
| 2147 | MAZE Maze Therapeutics, Inc. - Common Stock | 29.61 USD | +0.61% | +5.94% | +6.93% | -34.24% | 1.64 B USD | ||
| 2767 | CBIO Crescent Biopharma, Inc. - Common Stock | 16.96 USD | -1.11% | -2.97% | +0.89% | +7.55% | 629.96 M USD | ||
| 2786 | EIKN Eikon Therapeutics, Inc. - Common Stock | 11.11 USD | -2.46% | +6.11% | +23.44% | -34.84% | 601.77 M USD | ||
| 2936 | QTTB Q32 Bio Inc. - Common Stock | 16.33 USD | +2.25% | +2.38% | +6.38% | +720.60% | 486.14 M USD | ||
| 3154 | UPB Upstream Bio, Inc. - Common Stock | 6.59 USD | -5.45% | -7.70% | +1.85% | -62.56% | 360.94 M USD | ||
| 3347 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.81 USD | -1.99% | -1.43% | +1.40% | -11.25% | 291.71 M USD | ||
| 3729 | OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 3.88 USD | -1.52% | -5.60% | -7.40% | +58.37% | 157.13 M USD | ||
| 3938 | PTHS Pelthos Therapeutics Inc. Common Stock | 26.59 USD | +3.18% | +2.15% | -0.97% | +23.62% | 101.80 M USD | ||
| 3958 | PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.88 USD | -9.18% | -10.48% | -10.90% | -95.82% | 93.71 M USD | ||
| 3995 | DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 USD | +6.43% | +22.69% | +74.34% | -11.67% | 90.08 M USD | ||
| 4131 | OSTX OS Therapies Incorporated Common Stock | 1.55 USD | -2.52% | +4.03% | +1.97% | +34.78% | 71.50 M USD | ||
| 4187 | EXOZ eXoZymes Inc. - Common Stock | 6.95 USD | -5.83% | +15.26% | +45.40% | -28.35% | 64.51 M USD | ||
| 4267 | IBO Impact BioMedical, Inc. Common Stock | 0.47 USD | +2.17% | +2.17% | +9.30% | +6.82% | 50.68 M USD | ||
| 4281 | SCLX Scilex Holding Company - Common Stock | 5.66 USD | -1.22% | -11.56% | -17.37% | -30.38% | 48.07 M USD | ||
| 4423 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.80 USD | +5.26% | +1.27% | -9.09% | -44.06% | 33.62 M USD | ||
| 4583 | QCLS Q/C Technologies, Inc. - Common Stock | 2.43 USD | -5.81% | -13.52% | -28.74% | -46.00% | 19.90 M USD | ||
| 4649 | MDCX Medicus Pharma Ltd. - Common Stock | 0.26 USD | -3.70% | 0.00% | -31.58% | -77.97% | 16.43 M USD | ||
| 4864 | APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 4.65 USD | -0.43% | +20.16% | -18.13% | +254.96% | 7.02 M USD | ||
| 4931 | KAPA Kairos Pharma, Ltd. Common Stock | 0.24 USD | -17.24% | -25.00% | -17.24% | -58.62% | 5.69 M USD |
News Drug Manufacturers—General Stocks
Q2 Earnings Season Winds Down: 3 Companies That Broke Records
Where I’d Invest $10,000 Right Now
Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position - TipRanks.com
AbbVie Still Has Room To Run (NYSE:ABBV)
Will LQDA's Differentiated PAH Approach Drive Growth?
What’s Going On With Tempus AI Stock on Monday? - Tempus AI (NASDAQ:TEM)
Should You Buy Moderna Stock Following Its Cancer Breakthrough?
Gainers Drug Manufacturers—General Stocks
VBIO Valion Bio, Inc. - Common stock | 0.16 | +33.33% |
GENB Generate Biomedicines, Inc. - Common Stock | 17.71 | +9.86% |
PPCB Propanc Biopharma, Inc. - Common Stock | 1.16 | +7.41% |
DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 | +6.43% |
ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0600 | +6.38% |
MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.80 | +5.26% |
PTHS Pelthos Therapeutics Inc. Common Stock | 26.59 | +3.18% |
PVLA Palvella Therapeutics, Inc. - Common Stock | 145.85 | +2.68% |
Losers Drug Manufacturers—General Stocks
KAPA Kairos Pharma, Ltd. Common Stock | 0.24 | -17.24% |
PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.88 | -9.18% |
EXOZ eXoZymes Inc. - Common Stock | 6.95 | -5.83% |
QCLS Q/C Technologies, Inc. - Common Stock | 2.43 | -5.81% |
UPB Upstream Bio, Inc. - Common Stock | 6.59 | -5.45% |
ORKA Oruka Therapeutics, Inc. - Common Stock | 102.39 | -5.16% |
MANE Veradermics, Incorporated Common Stock | 98.33 | -4.48% |
MDCX Medicus Pharma Ltd. - Common Stock | 0.26 | -3.70% |